These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30988606)

  • 41. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 42. External Validation Of The Updated ADO Score In COPD Patients From The Birmingham COPD Cohort.
    Keene SJ; Jordan RE; Franssen FM; de Vries F; Martin J; Sitch A; Turner AM; Dickens AP; Fitzmaurice D; Adab P
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2395-2407. PubMed ID: 31749613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients.
    Chen X; Wang Q; Hu Y; Zhang L; Xiong W; Xu Y; Yu J; Wang Y
    Int J Chron Obstruct Pulmon Dis; 2020; 15():379-388. PubMed ID: 32110006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal change of FEV
    Jo YS; Kim SK; Park SJ; Um SJ; Park YB; Jung KS; Kim DK; Yoo KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():361-369. PubMed ID: 30787605
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease.
    van Geffen WH; Kerstjens HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1269-1277. PubMed ID: 29713160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.
    Jacobsen PA; van 't Hul AJ; Djamin RS; Antons JC; de Man M; Weinreich UM; Spruit MA; Janssen DJA
    Respir Res; 2021 May; 22(1):147. PubMed ID: 33980226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predicting frequent COPD exacerbations using primary care data.
    Kerkhof M; Freeman D; Jones R; Chisholm A; Price DB;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2439-50. PubMed ID: 26609229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission.
    Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
    Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
    PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations.
    Avriel A; Rozenberg D; Raviv Y; Heimer D; Bar-Shai A; Gavish R; Sheynin J; Douvdevani A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3153-3161. PubMed ID: 28003743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease.
    Kirby M; Pike D; Coxson HO; McCormack DG; Parraga G
    Radiology; 2014 Dec; 273(3):887-96. PubMed ID: 24960283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.
    Esteban C; Arostegui I; Garcia-Gutierrez S; Gonzalez N; Lafuente I; Bare M; Fernandez de Larrea N; Rivas F; Quintana JM;
    Respir Res; 2015 Dec; 16():151. PubMed ID: 26695935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.
    Boixeda R; Almagro P; Díez-Manglano J; Cabrera FJ; Recio J; Martin-Garrido I; Soriano JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2581-91. PubMed ID: 26664106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.